ESMO Congress

We are excited to share that we will join the ESMO Congress in Madrid. This outstanding event will disseminate the latest cutting-edge data, providing high quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.

Market access and P&R timelines are particularly critical for oncology therapies. In Alira Health, we advise companies to build a strong market access advantage from the earliest stages of development through evidence generation, regulation, and HTA to P&R negotiations and go-to-market strategies, in order to maximize patient access to these therapies.

Connect with our delegates at ESMO and learn how can we help you deliver your drug to oncology patients around the world.